2,4-Dichloro-5-fluoropyrimidine → 4-[2-(Benzyloxy)-4-fluorophenyl]-2-chloro-5-fluoropyrimidine
반응식
[Cl:1][C:2]1[N:7]=[C:6](Cl)[C:5]([F:9])=[CH:4][N:3]=1.[CH2:10]([O:17][C:18]1[CH:23]=[C:22]([F:24])[CH:21]=[CH:20][C:19]=1B(O)O)[C:11]1[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=1>>[CH2:10]([O:17][C:18]1[CH:23]=[C:22]([F:24])[CH:21]=[CH:20][C:19]=1[C:6]1[C:5]([F:9])=[CH:4][N:3]=[C:2]([Cl:1])[N:7]=1)[C:11]1[CH:12]=[CH:13][CH:14]=[CH:15][CH:16]=1참가 물질
3
실험 절차
was prepared under similar conditions as described in the preparation of Intermediate 1.4. using 2,4-dichloro-5-fluoropyrimidine (Aldrich Chemical Company Inc.) and [2-(benzyloxy)-4-fluorophenyl]boronic acid (ABCR GmbH & CO. KG). The batch was purified by column chromatography (hexane/ethyl acetate 1:1).
후처리
- customwas prepared under similar conditions
- customThe batch was purified by column chromatography (hexane/ethyl acetate 1:1)
출처 및 근거
- ORD 기록